Literature DB >> 7946786

Anticoagulation after intracoronary stent insertion.

M J Brack1, P J Hubner, A H Gershlick.   

Abstract

Stents rarely thrombose in the first 24 hours after implantation; secondly, heparin has some influence on the extrinsic pathway. Additionally, if too much heparin is present it interferes with the INR, and the half life of prothrombin suggests that the patient should be anticoagulated with heparin for up to 96 hours after starting warfarin. This is the evidence on which our standard protocol is based.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7946786      PMCID： PMC1025522          DOI： 10.1136/hrt.72.3.294

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  12 in total

Review 1.  Oral anticoagulant drugs.

Authors:  J Hirsh
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

2.  The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.

Authors:  F A Ofosu; P Sie; G J Modi; F Fernandez; M R Buchanan; M A Blajchman; B Boneu; J Hirsh
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

3.  The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin.

Authors:  I A Choonara; R G Malia; B P Haynes; C R Hay; S Cholerton; A M Breckenridge; F E Preston; B K Park
Journal:  Br J Clin Pharmacol       Date:  1988-01       Impact factor: 4.335

Review 4.  Determinants of the response to oral anticoagulant drugs in man.

Authors:  R A O'Reilly; P M Aggeler
Journal:  Pharmacol Rev       Date:  1970-03       Impact factor: 25.468

5.  Monitoring effects of oral anticoagulants during treatment with heparin.

Authors:  P Thomas; A Fennerty; G Backhouse; D P Bentley; I A Campbell; P A Routledge
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-21

6.  Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.

Authors:  G Schuler; R Hambrecht; G Schlierf; J Niebauer; K Hauer; J Neumann; E Hoberg; A Drinkmann; F Bacher; M Grunze
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

7.  Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.

Authors:  E M Conway; K A Bauer; S Barzegar; R D Rosenberg
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

8.  The mode of action of heparin in plasma.

Authors:  S Béguin; T Lindhout; H C Hemker
Journal:  Thromb Haemost       Date:  1988-12-22       Impact factor: 5.249

9.  Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.

Authors:  F A Ofosu; J Hirsh; C T Esmon; G J Modi; L M Smith; N Anvari; M R Buchanan; J W Fenton; M A Blajchman
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

10.  Quantitative angiographic follow-up of the coronary Wallstent in native vessels and bypass grafts (European experience--March 1986 to March 1990).

Authors:  B H Strauss; P W Serruys; M E Bertrand; J Puel; B Meier; J J Goy; L Kappenberger; A F Rickards; U Sigwart
Journal:  Am J Cardiol       Date:  1992-02-15       Impact factor: 2.778
View more
  2 in total

Review 1.  Antithrombotic therapy in the cardiac catheterization laboratory: focus on antiplatelet agents.

Authors:  M I Furman; A L Frelinger III; A D Michelson
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

2.  Antiplatelet therapy following stent deployment.

Authors:  A H Gershlick
Journal:  Heart       Date:  1997-10       Impact factor: 5.994
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.